| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ribosomal protein L35a | 0.736 | 0.385 | 0.90 |
|
phenotype | 0.300 | strong | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
ribosomal protein S24 | 0.695 | 0.423 | 0.68 |
|
phenotype | 0.300 | strong | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
ribosomal protein L26 | 0.695 | 0.423 | 0.92 |
|
phenotype | 0.300 | None | 0 | 0 | |||||||||||
|
ribosomal protein S28 | 0.716 | 0.423 | 0.68 |
|
phenotype | 0.300 | None | 0 | 0 | |||||||||||
|
ribosomal protein S29 | 0.729 | 0.423 | 0.29 |
|
phenotype | 0.300 | None | 0 | 0 | |||||||||||
|
ribosomal protein S7 | 0.682 | 0.462 | 0.95 |
|
phenotype | 0.300 | strong | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
ribosomal protein S10 | 0.729 | 0.462 | 0.97 |
|
phenotype | 0.300 | strong | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
ribosomal protein S17 | 0.751 | 0.462 | 0.33 |
|
phenotype | 0.300 | strong | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
ribosomal protein S26 | 0.716 | 0.538 | 0.85 |
|
phenotype | 0.300 | strong | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
ribosomal protein L11 | 0.650 | 0.577 | 0.96 |
|
phenotype | 0.300 | strong | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
ribosomal protein L5 | 0.617 | 0.615 | 1.00 |
|
phenotype | 0.300 | strong | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
RAD51 paralog C | 0.533 | 0.692 | 6.2E-14 |
|
phenotype | 0.300 | moderate | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
phenotype | 0.300 | strong | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
FA complementation group F | 0.535 | 0.731 | 0.46 |
|
phenotype | 0.300 | strong | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
FA complementation group L | 0.551 | 0.731 | 5.9E-23 |
|
phenotype | 0.300 | strong | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
FA complementation group I | 0.543 | 0.731 | 8.9E-37 |
|
phenotype | 0.300 | strong | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
FA complementation group M | 0.543 | 0.731 | 2.4E-15 |
|
phenotype | 0.300 | limited | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
BRCA1 interacting protein C-terminal helicase 1 | 0.507 | 0.731 | 6.2E-17 |
|
phenotype | 0.300 | strong | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
SLX4 structure-specific endonuclease subunit | 0.565 | 0.731 | 1.6E-22 |
|
phenotype | 0.300 | strong | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
phenotype | 0.300 | strong | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
FA complementation group G | 0.556 | 0.769 | 2.5E-14 |
|
phenotype | 0.300 | strong | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
T-box transcription factor 5 | 0.528 | 0.769 | 1.00 |
|
phenotype | 0.300 | strong | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
partner and localizer of BRCA2 | 0.485 | 0.769 | 3.0E-19 |
|
phenotype | 0.300 | strong | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
spalt like transcription factor 4 | 0.489 | 0.769 | 1.00 |
|
phenotype | 0.300 | strong | 0 | 0 | |||||||||||
|
T-box transcription factor 3 | 0.525 | 0.769 | 0.99 |
|
phenotype | 0.300 | strong | 0 | 0 |